Effect of Food Insulin Index on Metabolic Parameters in Obese Adolescents
1 other identifier
interventional
22
0 countries
N/A
Brief Summary
The aim of this study was to determine the effect of food insulin index (FII) on metabolic parameters and appetite in obese adolescents with insulin resistance. A randomized, single-blind and crossover trial included 15 obese adolescents aged 12-18 years with insulin resistance. All participants were submitted two different breakfasts: low glycemic index, low insulin index (LGI-LII) and low glycemic index, high insulin index (LGI-HII), with a 1-week washout period between meals. At time 0 (just before breakfast), 15, 30, 45, 60, 90, 120, 180 and 240 minutes after the meal, serum glucose, insulin and c-peptide levels were measured and appetite was evaluated by visual analog scale. At the end of four hours, participants were served ad libitum lunch meal. Then, the foods eaten at lunch were recorded and their energy and nutrient analysis was calculated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2016
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2017
CompletedFirst Submitted
Initial submission to the registry
December 12, 2017
CompletedFirst Posted
Study publicly available on registry
January 2, 2018
CompletedJanuary 2, 2018
December 1, 2017
4 months
December 12, 2017
December 28, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Postprandial glucose response
Postprandial glucose response was quantified as area under the curve (AUC) (mg/dL x minutes), which was calculated according to the trapezoidal rule by using serum glucose values at time points 0, 15, 30, 45, 60, 90, 120, 180 and 240 minutes.
Four hours postprandial period (from fasting to 240 minutes after the test breakfast)
Postprandial insulin response
Postprandial insulin response was quantified as AUC (μU/mL x minutes), which was calculated according to the trapezoidal rule by using serum insulin values at time points 0, 15, 30, 45, 60, 90, 120, 180 and 240 minutes.
Four hours postprandial period
Postprandial C-peptide response
Postprandial C-peptide response was quantified as AUC (ng/mL x minutes), which was calculated according to the trapezoidal rule by using serum C-peptide values at time points 0, 15, 30, 45, 60, 90, 120, 180 and 240 minutes.
Four hours postprandial period
Secondary Outcomes (14)
Hunger rating
Four hours postprandial period
Fullness rating
Four hours postprandial period
Desiring to eat
Four hours postprandial period
Prospective food consumption
Four hours postprandial period
Desiring for sweet
Four hours postprandial period
- +9 more secondary outcomes
Study Arms (2)
LGI-LII Breakfast
EXPERIMENTALLow glycemic index, low insulin index (LGI-LII) breakfast as a test meal
LGI-HII Breakfast
EXPERIMENTALLow glycemic index, high insulin index (LGI-HII) breakfast as a test meal
Interventions
This test meal with low GI and low FII amounts were served as a breakfast after 12-hours fasting and participants were asked to consume the meal in full, within 15 min.
In crossover design, this test meal with low GI and high FII amounts were served as a breakfast to compare the LGI-LII Breakfast.
Eligibility Criteria
You may qualify if:
- Aged 12-18 years
- Age- and sex-specific body mass index (BMI) ≥95th percentile of the World Health Organization (WHO) growth-reference data
- New diagnosis and not receiving any treatment
- Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) \>3.16
You may not qualify if:
- Hypertension, cardiovascular disease, diabetes mellitus or any other significant metabolic, endocrine or gastrointestinal disease
- Use of tobacco or alcohol
- Taking any medications
- Having difficulties for physical activity
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SCREENING
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor Doctor
Study Record Dates
First Submitted
December 12, 2017
First Posted
January 2, 2018
Study Start
November 1, 2016
Primary Completion
March 1, 2017
Study Completion
May 1, 2017
Last Updated
January 2, 2018
Record last verified: 2017-12